Indeed, BGJ398, a selective small-molecule inhibitor of FGFR1–3, increased the growth inhibitory effect of IM in both of the IM-sensitive GIST lines (GIST T-1 and 882) used in this study. The gene discussed is FGFR1; the disease is gastrointestinal stromal tumor.